Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)

Last updated: February 13, 2026

Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)

Watch later

Watch later

Infection prevention and control - Precautions and personal protective equipment (PPE): Nursing skills
Urinary tract infections (UTIs): Nursing process (ADPIE)
Modes of infectious disease transmission
Epstein-Barr virus (Infectious mononucleosis)
Pneumonia
Wound healing
Palliative and hospice care: Nursing
Postoperative care: Nursing
Biology of cancer: Nursing
Biliary atresia: Nursing
Cholecystitis: Nursing
Cholelithiasis: Nursing
Colorectal cancer: Nursing
Diarrhea: Nursing
Diverticular disease: Nursing
Esophageal cancer: Nursing
Gastric cancer: Nursing
Hepatitis: Nursing
Inflammatory bowel disease - Crohn disease and ulcerative colitis: Nursing
Intestinal obstruction: Nursing
Irritable bowel syndrome (IBS): Nursing
Jaundice: Nursing
Laryngeal cancer: Nursing
Liver cancer: Nursing
Pancreatic cancer: Nursing
Esophageal atresia and tracheoesophageal fistula: Nursing
Geriatric considerations - Gastrointestinal: Nursing
Hirschsprung disease: Nursing
Hyperemesis gravidarum: Nursing
Necrotizing enterocolitis: Nursing
Omphalocele and gastroschisis: Nursing
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antiemetics: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Laxatives: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Bladder tumors: Nursing
Chronic kidney disease (CKD): Nursing
Dialysis care: Nursing
Epididymitis: Nursing
Glomerulonephritis: Nursing
Nephrotic syndrome: Nursing
Polycystic kidney disease (PKD): Nursing
Prostate cancer: Nursing
Pyelonephritis: Nursing
Renal and urinary calculi: Nursing
Renal cancer: Nursing
Testicular cancer: Nursing
Urinary retention: Nursing
Bladder exstrophy: Nursing
Circumcision: Nursing
Cryptorchidism: Nursing
Enuresis: Nursing
Geriatric considerations - Urinary: Nursing
Hypospadias and epispadias: Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Anemia - Aplastic: Nursing
Anemia - Iron-deficiency: Nursing
Anemia - Macrocytic: Nursing
Arterial blood gas (ABG) - Overview: Nursing
Arterial blood gas (ABG) - Metabolic acidosis: Nursing
Arterial blood gas (ABG) - Metabolic alkalosis: Nursing
Arterial blood gas (ABG) - Respiratory acidosis: Nursing
Arterial blood gas (ABG) - Respiratory alkalosis: Nursing
Blood cultures: Nursing
Cardiac biomarkers - Creatine kinase (CK): Nursing
Cardiac biomarkers - Troponin: Nursing
Coagulation studies - Partial thromboplastin time (PTT): Nursing
Complete blood count (CBC) - Hemoglobin and hematocrit: Nursing
Complete blood count (CBC) - Platelets: Nursing
Complete blood count (CBC) - Red blood cells (RBC): Nursing
Complete blood count (CBC) - White blood cells (WBC) and differential: Nursing
Complete metabolic panel (CMP) - Blood urea nitrogen (BUN) and creatinine (Cr): Nursing
Complete metabolic panel (CMP) - Chloride: Nursing
Complete metabolic panel (CMP) - Estimated glomerular filtration rate (eGFR): Nursing
Complete metabolic panel (CMP) - Glucose: Nursing
Complete metabolic panel (CMP) - Liver function tests (LFT): Nursing
Complete metabolic panel (CMP) - Potassium: Nursing
Complete metabolic panel (CMP) - Sodium: Nursing
Complete metabolic panel (CMP) - Total protein: Nursing
Disseminated intravascular coagulation (DIC): Nursing
Multiple myeloma: Nursing
Neutropenia: Nursing
Polycythemia: Nursing
Thalassemia: Nursing
Thrombocytopenia: Nursing
Leukemia: Nursing process (ADPIE)
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Blood products: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Autoimmunity: Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type II: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Immune response - Adaptive: Nursing
Immune response - Innate: Nursing
Immunodeficiency disorders - Primary: Nursing
Immunodeficiency disorders - Secondary: Nursing
Inflammatory process: Nursing
Scleroderma: Nursing
Shock - Anaphylactic: Nursing
Sjögren syndrome: Nursing
Systemic lupus erythematosus (SLE): Nursing
Toxic shock syndrome (TSS): Nursing
Erythema infectiosum (Fifth disease): Nursing
Fever: Nursing
Infectious mononucleosis: Nursing
Mumps (Parotitis): Nursing
Neonatal sepsis: Nursing
Pertussis: Nursing
Poliomyelitis: Nursing
Postpartum infections: Nursing
Roseola (Exanthem subitum): Nursing
Rubella (German measles): Nursing
Rubeola (Measles): Nursing
Smallpox: Nursing
Zika virus: Nursing
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Antirejection immunosuppressants: Nursing pharmacology
Biologic agents: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Vaccines: Nursing pharmacology
Acne: Nursing
Animal and snake bites: Nursing
Burn injury: Nursing
Cutaneous fungal infections: Nursing
Erysipelas and cellulitis: Nursing
Folliculitis, carbuncles, and furuncles: Nursing
Herpes simplex virus (HSV): Nursing
Herpes zoster: Nursing
Impetigo: Nursing
Insect stings and bites: Nursing
Pediculosis and scabies: Nursing
Psoriasis: Nursing
Rocky Mountain spotted fever (RMSF): Nursing
Skin cancer - Basal cell carcinoma, squamous cell carcinoma, and melanoma: Nursing
Urticaria: Nursing
Geriatric considerations - Integumentary: Nursing
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Osteoarthritis: Nursing
Osteomyelitis: Nursing
Osteoporosis: Nursing
Hip fractures: Nursing
Developmental dysplasia of the hip: Nursing
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Buerger disease: Nursing
Raynaud phenomenon: Nursing
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Atelectasis: Nursing
Geriatric considerations - Respiratory: Nursing
Venous thromboembolism (VTE): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Bronchiolitis and respiratory syncytial virus (RSV): Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Papulosquamous and inflammatory skin disorders: Pathology review

Notes

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

KEY POINTS
NOTES
PATIENT REPORT
  • 67-year-old 
  • Emergency department
  • 3-day history of exertional breathlessness, wheezing, fatigue, cough
  • History: smoking x25 years
    • 2 packs per day
    • Recently quit smoking
  • Diagnosis: COPD

PATHOPHYSIOLOGY
  • Chronic lung disease with airflow obstruction 
  • Caused by chronic inflammation and lung damage 
  • Common causes 
    • Tobacco smoke 
    • Occupational pollutants 
    • Alpha-1 antitrypsin deficiency 
  • Pathophysiology 
    • Chronic bronchitis 
      • Inflammation of bronchial tubes 
      • Goblet cell hypersecretion → mucus plugs 
      • Airway obstruction and air trapping 
      • Chronic productive cough 
      • Symptoms
        • Exertional → resting dyspnea
        • Fatigue
        • Wheezing
        • Chest tightness 
    • Emphysema 
      • Alveolar destruction impairs gas exchange 
      • Loss of elastic recoil
        • Airway collapse during exhalation 
      • Air trapping and hyperinflation 
      • Barrel chest from increased AP diameter 
    • Compensatory mechanisms 
      • Tripod position 
      • Pursed-lip breathing 
    • COPD exacerbation 
      • Sustained worsening of respiratory symptoms beyond normal variability 
      • Symptoms 
        • Increased dyspnea 
        • Increased cough and sputum production 
        • Fatigue 
        • Increased wheezing 
        • Confusion or decreased consciousness 
  • Complications 
    • Hypoxemia 
    • Hypercapnia  
    • Cyanosis 
    • Pulmonary vasoconstriction
      • Pulmonary hypertension 
    • Right-sided heart failure 

DIAGNOSIS AND TREATMENT
  • Diagnosis 
    • History
    • Physical assessment
    • Pulmonary function test (PFT)
    • Alpha-1 antitrypsin deficiency screening
    • Arterial blood gas (ABG)
  • Treatment
    • Lifestyle modifications 
      • Smoking cessation 
      • Avoid triggers: pollution, allergens, occupational irritants 
      • Annual influenza vaccine 
      • Pneumococcal vaccine 
      • Adjust diet to maintain weight and muscle mass
      • High-calorie, high-protein meals 
    • Medications 
      • Bronchodilators 
      • Corticosteroids 
      • Oxygen therapy 
        • May need to maintain SpO2 between 88–92% 
        • Avoid 100% saturation to preserve respiratory drive 

ASSESSMENT
  • Patient sitting upright in tripod position 
  • Appears short of breath and tired 
  • Struggles to complete full sentences 
  • Nasal flaring and pursed-lip breathing observed 
  • Barrel chest 
  • Use of accessory muscles 
  • Ribs pulling inward during inspiration 
  • Expiratory wheezing 
  • Coarse crackles in lower lobes 
  • Capillary refill < 3 seconds 
  • Alert and oriented  
  • Vital signs 
    • Blood pressure: 135/80 mmHg 
    • Heart rate: 80/min
    • Respiratory rate: 26/min
    • Temperature: 98.6°F (37.0°C) 
    • Oxygen saturation: 87% room air 
    • Pain: 0/10 
  • ABG results 
    • pH: 7.34 
    • PaO₂: 62 mmHg (8.2 kPa)
    • PaCO₂: 65 mmHg (8.6 kPa)
    • HCO₃⁻: 32 mEq/L (32 mmol/L)

NURSING DIAGNOSES
  • Ineffective breathing pattern related to increased work of breathing
  • Ineffective airway clearance related to increased production of secretions
  • Impaired gas exchange related to airway destruction
  • Activity intolerance related to imbalance between oxygen supply and demand
  • Deficient knowledge related to chronic disease management

PLANNING
  • By end of shift, patient will
    • Have an effective breathing pattern as evidenced by breathing at a normal rate and depth
    • Have an absence of dyspnea, and no use of accessory muscles
    • Maintain clear, open airways as evidenced by clear breath sounds and ability to effectively cough up secretions
    • Demonstrate optimal gas exchange at 12 to 20/min
    • Have pulse oximetry at therapeutic levels during rest and exertion
    • Have blood gases be closer to normal range
    • Display increased activity tolerance evidenced by enhanced capacity and energy to ambulate 25 feet without feeling breathless
  • Prior to discharge patient will
    • Verbalize an understanding of COPD
    • Demonstrate how to use inhaler
    • Avoid triggers for exacerbations
    • Understand long-term management of COPD

IMPLEMENTATION
  • Vital signs monitored every 2 hours
  • Continuous respiratory assessment and  pulse oximetry
  • Supplemental oxygen 2L via nasal cannula 
    • Target SpO₂: 88–92% 
  • Medication  
    • Albuterol  
      • Administered via inhaler with spacer 
    • Prednisone 
  • Patient education 
    • Emphasized smoking cessation 
    • Discussed infection prevention 
  • Referral to physical therapist (PT) 
    • Assisting with breathing techniques and energy conservation during ADLs 
  • Referral to respiratory therapist (RT) 
    • Teaching breathing and airway clearance techniques 
    • Drawing blood for ABG analysis 

EVALUATION
  • Breathing less labored 
  • No longer using accessory muscles 
  • Effectively coughing up secretions 
  • 2L O2 via nasal cannula 
  • SpO2
    • 91% at rest 
    • Drops to 87% with minimal activity 
  • Mental status alert and oriented 
  • Tires easily but responsive 
  • Vital signs 
    • Blood pressure: 125/79 mmHg 
    • Heart rate: 90/min
    • Respiratory rate: 22/min 
    • Temperature: 98.6°F (37.0°C) 
    • Pain: 0/10 
  • ABG results 
    • pH: 7.40
    • PaO₂: 72 mmHg (9.5 kPa)
    • PaCO₂: 48 mmHg (6.3 kPa)
    • HCO₃⁻: 28 mEq/L  (28 mmol/L)
  • Continue reassessing respiratory status and oxygenation 
  • Determine if care plan adjustments are needed based on trends

Transcript

Watch video only

James Robyn is a 67-year-old male client who was brought to the emergency department, or ED, with a 3-day history of exertional breathlessness, wheezing, fatigue, and a worsening productive cough.

He states he has been having increased difficulty with normal day to day activities such as eating, talking and going up the stairs.

He has a history of cigarette smoking, two packs per day, since he was 25 years old.

However, he quit smoking a year ago after being diagnosed with chronic obstructive pulmonary disease, or COPD.

COPD, or chronic obstructive pulmonary disease, is a type of lung disease where chronic inflammation causes damage to the lungs and obstructs airflow.

It’s usually caused by inhalation of toxic substances, like tobacco smoke, or occupational pollutants like dust and silica.

In some people an autosomal dominant disorder called alpha-1 antitrypsin deficiency results in breakdown of the lung parenchyma by an enzyme called elastase.

COPD is characterized by long-term inflammation of the bronchial tubes, referred to as chronic bronchitis, and alveolar destruction, referred to as emphysema.

Most people diagnosed with COPD have elements of both chronic bronchitis and emphysema.

Chronic inflammation of the bronchial tubes in COPD causes a hypersecretion of mucus by the respiratory goblet cells.

The mucus then forms a plug that obstructs the airways causing air trapping, and it also causes chronic productive cough.

Obstruction of the bronchi can also cause exertional dyspnea, which can progress to resting dyspnea, fatigue, wheezing and chest tightness.

Destruction of the alveolar sacs impairs gas exchange, resulting in hypoxemia and hypercapnia.

Loss of elastic recoil causes collapse of the airways during exhalation, trapping the air and dilating the airspaces.

To make breathing easier, they often use the tripod position, where they sit up and lean forward with their hands on their knees.

They may use pursed lip breathing to prolong expiration and produce positive end-expiratory pressure, or PEEP, which allows them to breathe out as much air as possible.

Because this breathing technique requires use of accessory breathing muscles, they will expend a lot of energy just to breathe.

Air trapping also leads to an increased anteroposterior diameter of the chest, sometimes called a barrel chest.

Chronic hypoxemia can result in cyanosis, a bluish discoloration of the lips or fingertips.

It causes constriction of the pulmonary vessels and pulmonary hypertension.

This increases the workload on the right side of the heart, leading to right sided heart failure, or cor pulmonale.

Diagnosis of COPD is based on the client history, physical examination, and pulmonary function tests, or PFTs, to evaluate the degree of airway limitation.

The forced expiratory volume in one second, or FEV1, and the vital capacity, or FVC, are measured after the client is given a bronchodilator such as albuterol.

A FEV1/FVC ratio less than 70% indicates airway obstruction.

Since COPD is an irreversible disease, giving a bronchodilator does not change the person’s PFTs too much.

Finally, alpha-1 antitrypsin deficiency screening may also be done.

Long-term management for stable COPD includes smoking cessation and the avoidance of other triggers such as pollution and allergens.

Influenza and pneumococcal vaccines should be administered to decrease the risk of respiratory infections.

Although COPD is an irreversible disease, bronchodilators can help ease symptoms, and corticosteroids can decrease inflammation in the lungs.

Supplemental oxygen may be needed to maintain an oxygen saturation between 88 to 92 percent.

For these clients, the goal is not 100 percent saturation because hypoxemia is the main stimulus for their respiratory drive.

Finally, since these individuals expend much of their energy on simply breathing, dietary adjustments may be needed to maintain weight and muscle mass.

An exacerbation, or a sustained deterioration of their respiratory symptoms beyond their normal day to day variability, may manifest by increased dyspnea, cough, sputum production, and fatigue.

Increased wheezing may be noted and increased hypoxia may result in confusion or decreased level of consciousness.

Arterial blood gases, or ABGs, may show decreased PaO2, increased PaCO2, increased HCO3-, and decreased pH.

Okay, let’s get back to our client Mr. Robyn.

Since presenting to the ED, he has been admitted to the pulmonary ward for treatment of an acute exacerbation of COPD.

You have been assigned to his care.

After entering his room, you introduce yourself, wash your hands, and confirm his identity.

Mr. Robyn is sitting up on the side of his bed leaning over his bedside table in a tripod position.

You begin your assessment of Mr. Robyn by asking him how he is feeling today.

He states he is feeling short of breath and very tired.

You notice that he struggles to complete full sentences because he has to stop to breathe.

You notice nasal flaring and he is pursing his lips during expiration.

He states that he has had worsening respiratory symptoms for about a week including breathlessness when doing activities such as getting up to go to the bathroom, talking, and eating.

Sources

  1. "Ackley and Ladwig’s Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care, 13th edition" Mosby (2022)
  2. "Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease" N Engl J Med (2019)
  3. "The etiologic origins for chronic obstructive pulmonary disease" Int J Chron Obstruct Pulmon Dis (2019)
  4. "Harrison’s Principles of Internal Medicine, 21st edition" McGraw Hill / Medical (2022)
  5. "Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations" Clin Chest Med (2020)
  6. "Critical Care Nursing: Diagnosis and Management, 9th edition" Elsevier (2021)